197 related articles for article (PubMed ID: 17361206)
41. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
Wang G; Zhang Z; Ren Y
Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
[TBL] [Abstract][Full Text] [Related]
42. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds.
Hong M; Kim JW; Shin MK; Kim BC
J Korean Med Sci; 2017 Oct; 32(10):1595-1602. PubMed ID: 28875602
[TBL] [Abstract][Full Text] [Related]
43. MOC-31/Ep-CAM immunoreactivity in Merkel cells and Merkel cell carcinomas.
García-Caballero T; Pintos E; Gallego R; Parrado C; Blanco M; Bjornhagen V; Forteza J; Beiras A
Histopathology; 2003 Nov; 43(5):480-4. PubMed ID: 14636274
[TBL] [Abstract][Full Text] [Related]
44. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
[TBL] [Abstract][Full Text] [Related]
46. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.
Ralhan R; He HC; So AK; Tripathi SC; Kumar M; Hasan MR; Kaur J; Kashat L; MacMillan C; Chauhan SS; Freeman JL; Walfish PG
PLoS One; 2010 Nov; 5(11):e14130. PubMed ID: 21152431
[TBL] [Abstract][Full Text] [Related]
47. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.
Winter MJ; Nagtegaal ID; van Krieken JH; Litvinov SV
Am J Pathol; 2003 Dec; 163(6):2139-48. PubMed ID: 14633587
[TBL] [Abstract][Full Text] [Related]
48. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.
Litvinov SV; Bakker HA; Gourevitch MM; Velders MP; Warnaar SO
Cell Adhes Commun; 1994 Oct; 2(5):417-28. PubMed ID: 7842256
[TBL] [Abstract][Full Text] [Related]
49. Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1).
Patriarca C; Colombo P; Pio Taronna A; Wesseling J; Franchi G; Guddo F; Naspro R; Macchi RM; Giunta P; Di Pasquale M; Parente M; Arizzi C; Roncalli M; Campo B
Int J Surg Pathol; 2009 Apr; 17(2):99-106. PubMed ID: 19019843
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.
Lammers R; Giesert C; Grünebach F; Marxer A; Vogel W; Bühring HJ
Exp Hematol; 2002 Jun; 30(6):537-45. PubMed ID: 12063020
[TBL] [Abstract][Full Text] [Related]
51. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.
Litvinov SV; van Driel W; van Rhijn CM; Bakker HA; van Krieken H; Fleuren GJ; Warnaar SO
Am J Pathol; 1996 Mar; 148(3):865-75. PubMed ID: 8774141
[TBL] [Abstract][Full Text] [Related]
52. Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue.
Spizzo G; Gastl G; Obrist P; Fong D; Haun M; Grünewald K; Parson W; Eichmann C; Millinger S; Fiegl H; Margreiter R; Amberger A
Cancer Lett; 2007 Feb; 246(1-2):253-61. PubMed ID: 16624485
[TBL] [Abstract][Full Text] [Related]
53. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
[TBL] [Abstract][Full Text] [Related]
54. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
Went P; Vasei M; Bubendorf L; Terracciano L; Tornillo L; Riede U; Kononen J; Simon R; Sauter G; Baeuerle PA
Br J Cancer; 2006 Jan; 94(1):128-35. PubMed ID: 16404366
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma.
Mitra M; Kandalam M; Verma RS; UmaMaheswari K; Krishnakumar S
Mol Vis; 2010 May; 16():828-42. PubMed ID: 20461151
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of E-cadherin and Ep-CAM in cervical lymph node metastasis of supraglottic larynx carcinoma.
Ali Bayram ; Yüce İ; Çağlı S; Canöz Ö; Güney E
Am J Otolaryngol; 2015; 36(6):736-40. PubMed ID: 26545462
[TBL] [Abstract][Full Text] [Related]
57. [Expression of EP-CAM, beta-catenin in the carcinogenesis of squamous cell carcinoma of uterine cervix].
Yang JZ; Zhang XH; Wu WX; Yan X; Liu YL; Wang JL; Wang FR
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):372-5. PubMed ID: 12921570
[TBL] [Abstract][Full Text] [Related]
58. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
59. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
[TBL] [Abstract][Full Text] [Related]
60. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
